Correlation Between Merck and BRASKEM

Can any of the company-specific risk be diversified away by investing in both Merck and BRASKEM at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Merck and BRASKEM into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Merck Company and BRASKEM NETH FIN, you can compare the effects of market volatilities on Merck and BRASKEM and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Merck with a short position of BRASKEM. Check out your portfolio center. Please also check ongoing floating volatility patterns of Merck and BRASKEM.

Diversification Opportunities for Merck and BRASKEM

-0.78

Correlation Coefficient

Merck  BRASKEM

Pay attention - limited upside

The 3 months correlation between Merck and BRASKEM is -0.78. Overlapping area represents the amount of risk that can be diversified away by holding Merck Company and BRASKEM NETH FIN in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on BRASKEM NETH FIN and Merck is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Merck Company are associated (or correlated) with BRASKEM. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of BRASKEM NETH FIN has no effect on the direction of Merck i.e., Merck and BRASKEM go up and down completely randomly.

Pair Corralation between Merck and BRASKEM

Considering the 90-day investment horizon Merck Company is expected to under-perform the BRASKEM. But the stock apears to be less risky and, when comparing its historical volatility, Merck Company is 1.79 times less risky than BRASKEM. The stock trades about -0.19 of its potential returns per unit of risk. The BRASKEM NETH FIN is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest  9,290  in BRASKEM NETH FIN on September 5, 2024 and sell it today you would earn a total of  96.00  from holding BRASKEM NETH FIN or generate 1.03% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	35.94%
Values	Daily Returns

Merck Company  vs.  BRASKEM NETH FIN

Merck Company

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Merck Company has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain quite persistent which may send shares a bit higher in January 2025. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.

BRASKEM NETH FIN

Risk-Adjusted Performance

2 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in BRASKEM NETH FIN are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite somewhat strong basic indicators, BRASKEM is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with Merck and BRASKEM

The main advantage of trading using opposite Merck and BRASKEM positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Merck position performs unexpectedly, BRASKEM can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BRASKEM will offset losses from the drop in BRASKEM's long position.

The idea behind Merck Company and BRASKEM NETH FIN pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.